Peter Johnson is Professor of Medical Oncology at the University of Southampton and National Clinical Director for the NHSE cancer programme. He qualified in medicine from Cambridge and St Thomas's Medical School and trained in internal medicine in London. He completed oncology training and doctoral research at St Bartholomew’s Hospital as an Imperial Cancer Research Fund Clinical Research Fellow and he was a Senior Lecturer in the Leeds Cancer Centre. His research interests are in applied immunology and immunotherapy; lymphoma biology and precision medicine, and clinical trials. He has been the Chief Investigator for clinical trials ranging from first in human novel antibody therapeutics to international randomised studies, including the Cancer Research UK Stratified Medicine programme. He has published extensively on cancer biology and treatment, on novel biomarkers and their clinical evaluation.
His other appointments include Director of the Southampton Cancer Research UK Centre; Chair of the Royal College of Physicians Joint Specialty Committee for Medical Oncology; The Scientific Committee for the International Conference on Malignant Lymphoma and Executive Board member of the Cancer Immunotherapy (CIMT) Consortium. He was Chief Clinician for Cancer Research UK 2008-2017; Director of the Francis Crick Institute Cancer Research Network 2017-2019; a Trustee of the National Cancer Research Institute, a member of the board of the UK Clinical Research Collaboration and a member of the Genomics England Ltd Scientific Advisory Committee. In the NHS, he has been a member of the Cancer Clinical Outcomes Group for Haematologic Malignancy; the Health Education England Genomics Advisory Board, and advisor to the NHS Chief Executive's Review of Innovation.